
Liquid biopsy research: a generous boost to help children with cancer
A Montreal research team, headed by the eminent Janusz Rak, MD, PhD, continues to lead the way to the “next frontier” in pediatric cancer screening, diagnosis...

Canada's Top 40 Research Hospitals: three years in the top 3!
Thanks to RI-MUHC researchers, trainees and staff, the MUHC maintains its leadership position in the Canadian research ecosystem

Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.

Dr. Carolyn Freeman named to Order of Canada
A passion to change the lives of cancer patients, young and old

Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.

Happy first anniversary to the Quebec SmartCare Consortium!
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...

$2 million USD to investigate new approaches for prostate cancer treatment
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...

Another honour for Dr. Phil Gold
Dr. Phil Gold recently received the McGill Medal

The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz